Tag: CDK inhibitor

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to CDK inhibitor

CDK Inhibitors Market Predictable to Witness Sustainable Evolution Over 2020 – Roche, Teijin ...

Added to Collection on: 2020-12-08 17:48:45

Tags for this article:

Business
Health sciences
Business process
Marketing strategy
CDK inhibitor
Cyclacel
Market segmentation
Market analysis
Market share
Merck & Co.
Pharmaceutical industry in China

Click the tags to see associated articles and topics

View Article Details
Trilaciclib Administered Prior to Chemotherapy Enhances Immune System Reaction in Metastatic ...

Added to Collection on: 2020-12-10 17:48:45

Tags for this article:

Clinical medicine
Medicine
Cancer treatments
Breakthrough therapy
Protein kinase inhibitors
Chemotherapy
Occupational safety and health
Oncology
PD-1 and PD-L1 inhibitors
Triple-negative breast cancer
CDK inhibitor
Palbociclib
San Antonio

Click the tags to see associated articles and topics

View Article Details
Global Cancer CDK Inhibitor Market 2019-2029 - Pipeline Analysis is estimated to be US$ 16.1 ...

Added to Collection on: 2021-03-17 15:33:45

Tags for this article:

Chemical compounds
Protein kinase inhibitors
Organic compounds
Piperazines
Cell cycle
Breakthrough therapy
Cyclopentanes
CDK inhibitor
Palbociclib
Cyclin-dependent kinase
Novartis
Abemaciclib

Click the tags to see associated articles and topics

View Article Details
Identifying Interstitial Lung Disease

Added to Collection on: 2021-06-18 18:00:00

Tags for this article:

Cancer immunotherapy
Clinical medicine
Medicine
Chemical compounds
Protein kinase inhibitors
Breakthrough therapy
Lung disorders
Lung cancer
PD-1 and PD-L1 inhibitors
Interstitial lung disease
Immunotherapy
CDK inhibitor

Click the tags to see associated articles and topics

View Article Details
HER2-Negative Breast Cancer Pipeline, FDA Approvals, Unmet - openPR.com

Added to Collection on: 2024-05-19 18:38:41

Tags for this article:

Antineoplastic drugs
Immunology
Breast cancer
HER2
Trastuzumab
CDK inhibitor
Genentech
Selective estrogen receptor degrader
Antibody-drug conjugate
Immutep
Inavolisib
Hormone receptor positive breast tumor
DelveInsight Business Research LLP

Click the tags to see associated articles and topics

View Article Details
No OS Difference Among First-Line CDK4/6 Inhibitors in HR+/HER2- mBC

Added to Collection on: 2024-12-12 19:17:48

Tags for this article:

Cyclopentanes
Protein kinase inhibitors
Oncogenes
Pyridines
Lactams
Palbociclib
Cyclin-dependent kinase 4
HER2
Ribociclib
Breast cancer
Abemaciclib
CDK inhibitor
San Antonio
Kari B. Wisinski
United States

Click the tags to see associated articles and topics

View Article Details
Pfizer's IBRANCE® in Combination with Standard-of-Care Therapies Extends Median ...

Added to Collection on: 2024-12-14 15:49:52

Tags for this article:

Specialty drugs
Antineoplastic drugs
Breast cancer
Cyclopentanes
Lactams
Palbociclib
HER2
Pertuzumab
Trastuzumab
CDK inhibitor
Dalpiciclib
New York
Pfizer Inc.
I Pfizer Inc.

Click the tags to see associated articles and topics

View Article Details
The Targeted Pulse: FDA Approvals, Real-World Insights, and Precision Oncology Advances

Added to Collection on: 2025-07-13 11:04:59

Tags for this article:

Lung cancer
Cyclopentanes
Protein kinase inhibitors
Antineoplastic drugs
Tyrosine kinase inhibitors
Palbociclib
Sunvozertinib
Non-small-cell lung cancer
Targeted therapy
Ribociclib
CDK inhibitor
Treatment of lung cancer

Click the tags to see associated articles and topics

View Article Details
Celcuity shares triple on late-stage results for breast cancer therapy | BioPharma Dive

Added to Collection on: 2025-07-28 16:43:42

Tags for this article:

Breast cancer
Cyclopentanes
Lactams
Protein kinase inhibitors
Specialty drugs
Palbociclib
Fulvestrant
HER2
CDK inhibitor
Dalpiciclib
Celcuity

Click the tags to see associated articles and topics

View Article Details
Breakthrough in Breast Cancer for 2.3 Million Women: evERA Trial Delivers 70% ER ...

Added to Collection on: 2025-09-25 21:15:13

Tags for this article:

Antineoplastic drugs
Selective estrogen receptor degraders
Breast cancer
Organofluorides
Beta-Carbolines
Giredestrant
Everolimus
CDK inhibitor
HER2
Ribociclib
Cancer
Endocrine therapy resistance in breast cancer

Click the tags to see associated articles and topics

View Article Details
Book a Demo